Unicycive Therapeutics Inc (UNCY)

Precedente Chiudi:

$1.12

Aprire:

$1.15

Volume 24 ore:

168.64K

Capitalizzazione di mercato:

$38.93M

Reddito:

-

Utile/perdita netta:

$-30.54M

Rapporto P/E:

-0.5657

EPS:

-1.98

Flusso di cassa netto:

$-18.30M

1 W Prestazione:

+8.74%

1M Prestazione:

-18.25%

6M Prestazione:

+86.98%

1 anno Prestazione:

-9.68%

Intervallo 1D:

$1.1097

$1.15

Portata 52W:

$0.47

$1.8227

Unicycive Therapeutics Inc Stock (UNCY) Company Profile

Nome

Unicycive Therapeutics Inc

Settore

Healthcare (1213)

Industria

Biotechnology (699)

Telefono

650 351 4495

Indirizzo

4300 El Camino Real, Suite 210, Los Altos

Dipendente

9

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

UNCY's Discussions on Twitter

Unicycive Therapeutics Inc Borsa (UNCY) Ultime notizie

Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

GlobeNewswire Inc.

Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire Inc.

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

GlobeNewswire Inc.

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Unicycive Announces $50 Million Private Placement

GlobeNewswire Inc.

Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference

GlobeNewswire Inc.

Unicycive Therapeutics Inc Azioni (UNCY) Dati Finanziari

Unicycive Therapeutics Inc (UNCY) Reddito netto 2024

Unicycive Therapeutics Inc (UNCY) Flusso di cassa 2024

Unicycive Therapeutics Inc (UNCY) Utile per azione 2024